Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion description "[Increased expression of integrin ?1, ?5, and/or ?2 was also observed in refractory tumor samples from patients with lung cancer treated with erlotinib and/or gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion evidence source_evidence_literature NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion SIO_000772 23872583 NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion wasDerivedFrom befree-2016 NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_assertion wasGeneratedBy ECO_0000203 NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1095412.RAaRsyU8hFOUy0IFnyKlSbc6LhOn0fw3zI1y4eEdqbRk4130_provenance.